Side-by-side comparison of AI visibility scores, market position, and capabilities
Tempe AZ US solar module leader (NASDAQ: FSLR) at $4.2B 2024 revenue (+27%) with 23.5 GW total capacity; $330M South Carolina factory adding 3.7 GW and EPEAT Climate+ certified competing with Qcells for IRA-compliant domestic utility solar.
First Solar, Inc. is a Tempe, Arizona-based solar module manufacturer — publicly traded on NASDAQ (NASDAQ: FSLR) as an S&P 500 component — operating as the largest US solar manufacturer and the only vertically integrated thin-film cadmium telluride (CdTe) solar module company at commercial scale, with 23.5 GW of total nameplate manufacturing capacity across facilities in the United States (Ohio, Alabama, Louisiana), India, Vietnam, and Malaysia as of 2025. In fiscal year 2024, First Solar reported $4.2 billion in net sales (a 27% increase from $3.3 billion in 2023) with a record 14.1 GW of modules sold. In 2025, First Solar committed $330 million to a new South Carolina factory in Gaffney (3.7 GW capacity, ~600 jobs, operations H2 2026) that would bring total US capacity to 17.7 GW. First Solar's CdTe modules have achieved commercial production efficiencies exceeding 20%, and the company holds first-mover status with the EPEAT Climate+ designation for ultra-low carbon solar technology. CEO Mark Widmar leads the company. Founded 1990 in Perrysburg, Ohio.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.